Electrophysiological features in acromegaly: re-thinking the arrhythmic risk?
- 6 July 2020
- journal article
- review article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 44 (2) , 209-221
Abstract
Background Acromegaly is disease associated with a specific cardiomyopathy. Hitherto, it has been widely understood that acromegaly carries an increased risk of arrhythmia. Purpose In this review we show that evidences are limited to a small number of case–control studies that reported increased rates of premature ventricular beats (PVB) but no more significant arrhythmia. In contrast, there are several studies that have reported impaired preclinical markers of arrhythmia, including reduced heart rate variability, increased late potentials, QT interval dispersion, impaired heart rate recovery after physical exercise and left ventricular dysynchrony. Whilst these markers are associated with an adverse cardiovascular prognosis in the general population, they do not have a high independent positive predictive accuracy for arrhythmia. In acromegaly, case reports have described sudden cardiac death, ventricular tachyarrhythmia and advanced atrio-ventricular block that required implantation of a cardio-defibrillator or permanent pacemaker. Treatment with somatostatin analogues can reduce cardiac dysrhythmia in some cases by reducing heart rate, PVBs and QT interval. Pegvisomant reduces mean heart rate. Pasireotide is associated with QT prolongation. In the absence of good quality data on risk of arrhythmia in acromegaly, the majority of position statements and guidelines suggest routine 12-lead electrocardiography (ECG) and transthoracic echocardiography (TTE) in every patient at diagnosis and then follow up dependent on initial findings.Keywords
This publication has 90 references indexed in Scilit:
- Cardiovascular involvement in patients affected by acromegaly: An appraisalInternational Journal of Cardiology, 2013
- Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension studyPituitary, 2013
- A consensus on the diagnosis and treatment of acromegaly complicationsPituitary, 2012
- Cardiac T-type Ca2+ channels in the heartJournal of Molecular and Cellular Cardiology, 2010
- Acromegaly pathogenesis and treatmentJournal of Clinical Investigation, 2009
- Late potentials and ventricular arrhythmias in acromegalyInternational Journal of Cardiology, 2005
- Emergency pacemaker implantation in acromegalyInternational Journal of Cardiology, 2004
- Heart-Rate Recovery Immediately after Exercise as a Predictor of MortalityNew England Journal of Medicine, 1999
- Modulation of Cardiac Ca2+Channels by IGF1Biochemical and Biophysical Research Communications, 1998
- Approaches to Sudden Death from Coronary Heart DiseaseCirculation, 1971